Skip to main content

Table 1 Preoperative patient characteristics

From: Continuous or interrupted pledgeted suture technique in stented bioprosthetic aortic valve replacement: a comparison of in-hospital outcomes

 

All patients (N = 1356)

CST (N = 791)

IPT (N = 565)

p-value

Age (mean, sd/median, IQR)

72.4 (8.8)

73 (67–80)

74 (66–78)

0.02

Gender (Male)

58%

56%

60%

0.07

Diabetes Mellitus

25%

26%

25%

0.90

Hypertension

75%

74%

76%

0.28

Creatinine level (mg/dl)

1.08 (0.86–2.34)

1.11 (0.87–2.62)

1.04 (0.85–1.45)

0.10

Hypercholesterolemia

66%

68%

65%

0.27

NYHA

   

0.53

I

24%

24%

24%

 

II

45%

46%

44%

 

III

28%

27%

28%

 

IV

3%

3%

4%

 

Previous cardiac surgery

12.1%

12.7%

11.3%

0.45

BSA (median, IQR)

1.9 (1.8–2.2)

2.0 (1.8–2.2)

1.9 (1.7–2.1)

0.10

BMI (median, IQR)

28 (26–33)

28 (25–32)

28 (24–33)

0.13

Euroscore II (mean, sd)

3.6 (4.3)

3.6 (4.5)

3.5 (4.1)

0.80

Previuos CVA or carotid

stenosis > 70%

4.2%

2.2%

2.0%

0.41

Concomittant procedures

    

CABG

33.5%

35.0%

31.3%

0.16

MVP

6.3%

7.3%

4.9%

0.07

MVR

5.4%

4.9%

6.2%

0.32

TVP

2.1%

2.1%

1.9%

0.79

Ascending aorta

7.1%

7.2%

6.9%

0.81

AF ablation

2.6%

2.5%

2.6%

0.90

Septal myectomy

4.5%

4.4%

4.6%

0.89

ASD closure

0.9%

0.9%

0.9%

0.99

VSD closure

0.1%

0.1%

0%

0.40

Indication for operation

   

0.16

Stenosis

87.6%

85.3%

89.4%

 

Regurgitation

6.0%

6.6%

5.1%

 

Mixed type

6.4%

8.1%

5.5%

 

Endocarditis (active)

3.5%

2.9%

0.6%

0.001

Full sternotomy

88.5%

88.2%

88.9%

0.70

Mini-sternotomy

(Upper Hemi)

11.5%

11.8%

11.1%

0.62

  1. CST: Continues suture technique; IPT: Interrupted pledgeted technique; NYHA: New York Heart Association; BSA: Body surface area; BMI: Body mass index; CABG: Coronary artery bypass graft; NVP: Mitral valve plasty; MVR: Mitral valve replacement; AF: Atrial fibrillation; ASD: Atrial septal defect; VSD: Ventricular septal defect